Immunoassay Market Outlook:
Immunoassay Market size was over USD 33.31 billion in 2025 and is poised to exceed USD 54.78 billion by 2035, witnessing over 5.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of immunoassay is estimated at USD 34.84 billion.
The growth of the market is set to be dominated by the rising prevalence of infectious diseases such as COVID-19. Across the globe, over 767 million cases of Covid-19 were recorded as of June 13, 2023. Hence, the demand for immunoassay is also predicted to rise. This is because to detect both IgM and IgG against SARS-CoV-2, the immunoassay has been significantly researched as a point-of-care (POC) test.
Moreover, the immunoassay market is also surging on account of growing demand for point-of-care diagnostics throughout the forecast period. This rise in demand for point-of-care diagnostics is primarily influenced by the escalating demand for quick and efficient solutions for diagnostics in diverse healthcare settings. Point-of-care diagnostics, distinguished by their directness and convenience, resonate with advanced healthcare dynamics, boosting a paradigm move in the management of patients. Immunoassays which are studied for their specificity and sensitivity, appear as crucial contributors to this paradigm move, aligning continuously with the need for point-of-care applications.
